Available Verisk Health Speakers
Nadine is responsible for strategic partnerships, sales...
Executive Vice President
Nadine is a healthcare IT expert and can speak on a variety of topics related to risk assessment and mitigation—including risk effecting specific healthcare industry players (providers, payers, and employers) and the tactical strategies needed to improve clinical and financial outcomes. As a solution-to-market expert, Nadine can speak on the use of predictive modeling and data analytics to reduce healthcare costs, and to optimize quality, performance, budgeting and underwriting.
Nadine Hays is responsible for strategic partnerships, sales, and marketing across the several healthcare market segments served by Verisk Health. She also oversees the company's international operations.
She has nearly 20 years of experience in clinical informatics and healthcare IT, working with several leaders in the industry to introduce innovative solutions for managing the quality and cost of care. Prior to joining Verisk Health, Nadine was the Chief Marketing Officer of D2Hawkeye, a healthcare data analytics company acquired by Verisk Health in 2009.
Before leading the marketing and sales teams at D2, Nadine led the strategy and business development team for McKesson Health Solutions, the integrated care management and claims performance arm of McKesson Inc. She also served as an executive at various healthcare and software companies, including Ingenix, Iameter and National Healthtech. Nadine is a licensed attorney, having practiced as a securities specialist for several years.
Nadine has a BA from the University of California, Santa Barbara and a JD from Loyola Law School in Los Angeles, CA.
As the senior executive of Verisk Health, Joel Portice...
President, Payment Accuracy Division
As the senior executive of Verisk Health, Joel Portice has led the company through its unprecedented growth and scope expansion. In his role, Joel is responsible for the overall performance and strategic direction of Verisk Health. Prior to assuming his current position, Joel was President and CEO of Intelimedix, a healthcare data analytics and software company, which was acquired by Blue Health Intelligence. Before leading Intelimedix, Joel served as COO at Verisk's HCI division, where he developed and executed the growth strategy, including product management, financial performance and product enhancements, while also leading overall operations with profit and loss oversight.
Before joining Verisk, he co-founded Enclarity, Inc. a healthcare information management and analytics solutions company, and managed the majority ownership sale to a private equity consortium. Prior to launching Enclarity, he was VP of Healthcare and Insurance Analytics for Fair Isaac Corporation, where he led the growth and integration of the healthcare and insurance analytic assets for the company. Joel also co-founded Integrity Plus Services, a cost-containment software and services company that served the healthcare and insurance markets. IPS was acquired by UnitedHealth Group.
Joel received his bachelor of science degree from the University of South Dakota and a master of arts degree from Hamline University. He is Trustee Emeritus for Hamline University and on the board of advisors for the Center for Health Care Management and Policy of the Paul Merage School of Business at the University of California, Irvine.
Arlene Ash, PhD
Arlene Ash is an expert on the research and science of health...
Arlene Ash, PhD
Arlene Ash is an expert on the research and science of health-risk adjustment. She is a frequent speaker on the topic and has published her work in many peer-reviewed medical journals.
Dr. Ash cofounded DxCG, a unit of Verisk Health, where she continues as senior scientist. She also serves as professor at UMASS Medical School and as an adjunct professor at Boston University's Schools of Medicine.
Dr. Ash is an internationally recognized expert in the development and use of risk-adjustment methodologies and an experienced user of national research databases, especially for Medicare. Medicare has adapted her Diagnostic Cost Group models for use in HMO payment.
She is a Fellow of AcademyHealth and of the American Statistical Association, a recent Past Chair of ASA’s Health Policy Statistics Section, and a winner of the American Public Health Association Statistics Section’s 2003 outstanding statistician in industry award. She holds a PhD in mathematics and statistics from the University of Illinois, an MS from Washington University, and a BA from Harvard University.